Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
The SEC charged the asset manager with misleading clients over changes to its retirement funds, leading to higher tax bills for investors.
Adoption of the cryptocurrency has outpaced other transformative technologies like the internet and mobile phones.
The chief growth officer is at the forefront of preparing RIAs to grow their businesses and train advisors for the future.